Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Deletion of SUMO1 attenuates behavioral and anatomical deficits by regulating autophagic activities in Huntington disease
Uri Nimrod Ramírez-Jarquín, Manish Sharma, Wuyue Zhou, et al.
Proceedings of the National Academy of Sciences (2022) Vol. 119, Iss. 5
Open Access | Times Cited: 29

Showing 1-25 of 29 citing articles:

Sumoylation in Physiology, Pathology and Therapy
Umut Şahin, Hugues de Thé, Valérie Lallemand-Breitenbach
Cells (2022) Vol. 11, Iss. 5, pp. 814-814
Open Access | Times Cited: 52
Ubiquitin and Ubiquitin-like Proteins in Cancer, Neurodegenerative Disorders, and Heart Diseases
Jin‐Taek Hwang, Ah Young Lee, Changwon Kho
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 9, pp. 5053-5053
Open Access | Times Cited: 43
Ubiquitin specific peptidase 11 knockdown slows Huntington’s disease progression via regulating mitochondrial dysfunction and neuronal damage depending on PTEN-mediated AKT pathway
Bai Gao, Yuchen Jing, Xi Li, et al.
Molecular Medicine (2025) Vol. 31, Iss. 1
Open Access | Times Cited: 1
Autophagy and neurodegeneration: Unraveling the role of C9ORF72 in the regulation of autophagy and its relationship to ALS-FTD pathology
Rim Diab, Federica Pilotto, Smita Saxena
Frontiers in Cellular Neuroscience (2023) Vol. 17
Open Access | Times Cited: 18
Interaction between autophagy and the NLRP3 inflammasome in Alzheimer’s and Parkinson’s disease
Ranran Lu, Lijie Zhang, Xinling Yang
Frontiers in Aging Neuroscience (2022) Vol. 14
Open Access | Times Cited: 27
Rhes, a striatal enriched protein, regulates post-translational small-ubiquitin-like-modifier (SUMO) modification of nuclear proteins and alters gene expression
Oscar Rivera, Manish Sharma, Sunayana Dagar, et al.
Cellular and Molecular Life Sciences (2024) Vol. 81, Iss. 1
Open Access | Times Cited: 5
Paralogue-Specific Roles of SUMO1 and SUMO2/3 in Protein Quality Control and Associated Diseases
Wei Wang, Michael J. Matunis
Cells (2023) Vol. 13, Iss. 1, pp. 8-8
Open Access | Times Cited: 11
Retinal dysfunction in Huntington’s disease mouse models concurs with local gliosis and microglia activation
Fátima Cano-Cano, Francisco Martín-Loro, Andrea Gallardo-Orihuela, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 4
Protein modification in neurodegenerative diseases
Shahin Ramazi, Maedeh Dadzadi, Mona Darvazi, et al.
MedComm (2024) Vol. 5, Iss. 8
Open Access | Times Cited: 4
The N17 domain of huntingtin as a multifaceted player in Huntington’s disease
Hyun-Ju Cho
Frontiers in Molecular Biosciences (2025) Vol. 11
Open Access
Abnormal molecular signatures of inflammation, energy metabolism, and vesicle biology in human Huntington disease peripheral tissues
Andreas Neueder, Kerstin Kojer, Tanja Hering, et al.
Genome biology (2022) Vol. 23, Iss. 1
Open Access | Times Cited: 15
Paradoxes of Cellular SUMOylation Regulation: A Role of Biomolecular Condensates?
Xiaodong Cheng, Wenli Yang, Wei Lin, et al.
Pharmacological Reviews (2023) Vol. 75, Iss. 5, pp. 979-1006
Open Access | Times Cited: 9
Tunneling Nanotube: An Enticing Cell–Cell Communication in the Nervous System
Sunayana Dagar, Srinivasa Subramaniam
Biology (2023) Vol. 12, Iss. 10, pp. 1288-1288
Open Access | Times Cited: 9
Correction of symptoms of Huntington disease by genistein through FOXO3-mediated autophagy stimulation
Karolina Pierzynowska, Magdalena Podlacha, Lidia Gaffke, et al.
Autophagy (2023) Vol. 20, Iss. 5, pp. 1159-1182
Open Access | Times Cited: 8
Protein Kinase CK2 and Its Potential Role as a Therapeutic Target in Huntington’s Disease
Angel White, Anna McGlone, Rocío Gómez‐Pastor
Biomedicines (2022) Vol. 10, Iss. 8, pp. 1979-1979
Open Access | Times Cited: 13
Huntingtin Interacting Proteins and Pathological Implications
Li Liu, Huichun Tong, Yize Sun, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 17, pp. 13060-13060
Open Access | Times Cited: 6
HD and SCA1: Tales from two 30-year journeys since gene discovery
Leslie M. Thompson, Harry T. Orr
Neuron (2023) Vol. 111, Iss. 22, pp. 3517-3530
Closed Access | Times Cited: 6
Pharmacological Activities of Ginkgolic Acids in Relation to Autophagy
Yuan Ding, Zheheng Ding, Jin Xu, et al.
Pharmaceuticals (2022) Vol. 15, Iss. 12, pp. 1469-1469
Open Access | Times Cited: 9
Mutant-Huntingtin Molecular Pathways Elucidate New Targets for Drug Repurposing
V.S. Makeeva, Nadezhda S. Dyrkheeva, Olga I. Lavrik, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 23, pp. 16798-16798
Open Access | Times Cited: 5
Enamel defects in Acp4R110C/R110C mice and human ACP4 mutations
Tian Liang, Shih‐Kai Wang, Charles E. Smith, et al.
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 8
Analysis of a degron-containing reporter protein GFP-CL1 reveals a role for SUMO1 in cytosolic protein quality control
Wei Wang, Jian R. Lu, Wei-Chih Yang, et al.
Journal of Biological Chemistry (2022) Vol. 299, Iss. 2, pp. 102851-102851
Open Access | Times Cited: 6
Leucine‐rich repeat kinase 2 (LRRK2) inhibition upregulates microtubule‐associated protein 1B to ameliorate lysosomal dysfunction and parkinsonism
Kang Chen, Fei Tang, Bin Du, et al.
MedComm (2023) Vol. 4, Iss. 6
Open Access | Times Cited: 3
Striatal Induction and Spread of the Huntington’s Disease Protein: A Novel Rhes Route
Srinivasa Subramaniam
Journal of Huntington s Disease (2022) Vol. 11, Iss. 3, pp. 281-290
Open Access | Times Cited: 5
Ubiquitin Specific Peptidase 11 Knockdown Slows Huntington's Disease Progression via Regulating Mitochondrial Dysfunction and Neuronal Apoptosis Depending on PTEN- mediated AKT Pathway
Bai Gao, Yuchen Jing, Xi Li, et al.
Research Square (Research Square) (2024)
Closed Access
Recent pharmacological insights on abating toxic protein species burden in neurological disorders: Emphasis on 26S proteasome activation
Mahmoud A. Desouky, Haidy E. Michel, Doaa A. Elsherbiny, et al.
Life Sciences (2024) Vol. 359, pp. 123206-123206
Closed Access
Page 1 - Next Page

Scroll to top